Myriad Genetics Agrees to Sell Prenatal Testing Business to Labcorp
Myriad Genetics agreed to sell its Prenatal Health testing business to Labcorp for $210 million in cash plus inventory value. Myriad shares rose 22.2% in premarket trading.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.